Sridevi Jaksani

4.3k total citations
6 papers, 540 citations indexed

About

Sridevi Jaksani is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Sridevi Jaksani has authored 6 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Surgery and 2 papers in Genetics. Recurrent topics in Sridevi Jaksani's work include Tissue Engineering and Regenerative Medicine (3 papers), Mesenchymal stem cell research (2 papers) and MicroRNA in disease regulation (2 papers). Sridevi Jaksani is often cited by papers focused on Tissue Engineering and Regenerative Medicine (3 papers), Mesenchymal stem cell research (2 papers) and MicroRNA in disease regulation (2 papers). Sridevi Jaksani collaborates with scholars based in Netherlands, Canada and Germany. Sridevi Jaksani's co-authors include Joost P. G. Sluijter, Pieter A. Doevendans, Marish I.F.J. Oerlemans, Alain van Mil, Bernard A.J. Roelen, Juliette van den Dolder, Marie‐José Goumans, Karlijn J. Wilschut, Sebastian Grundmann and Zhiyong Lei and has published in prestigious journals such as Nature Medicine, Oncogene and Cardiovascular Research.

In The Last Decade

Sridevi Jaksani

6 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sridevi Jaksani Netherlands	6	394	144	98	93	87	6	540
Sonia Talma United Kingdom	6	183 0.5×	104 0.7×	66 0.7×	67 0.7×	51 0.6×	8	396
Knut Niß United States	10	362 0.9×	90 0.6×	80 0.8×	55 0.6×	214 2.5×	11	756
Hanneke N. Monsuur Netherlands	12	273 0.7×	96 0.7×	115 1.2×	40 0.4×	60 0.7×	17	635
Krishna K. Kolluri United Kingdom	12	336 0.9×	157 1.1×	91 0.9×	64 0.7×	139 1.6×	22	537
Gertrudis Ligero Spain	15	645 1.6×	187 1.3×	44 0.4×	141 1.5×	159 1.8×	22	826
Marina Cihova Slovakia	13	344 0.9×	144 1.0×	243 2.5×	78 0.8×	174 2.0×	20	664
Jotaro Suzuki Japan	6	1.0k 2.6×	124 0.9×	201 2.1×	145 1.6×	84 1.0×	9	1.2k
Victoria Zismanov Israel	14	384 1.0×	58 0.4×	103 1.1×	64 0.7×	70 0.8×	20	559
Karen A. Boehme Germany	8	346 0.9×	86 0.6×	185 1.9×	52 0.6×	30 0.3×	12	524
Ee-chun Cheng United States	12	489 1.2×	123 0.9×	39 0.4×	94 1.0×	112 1.3×	18	766

Countries citing papers authored by Sridevi Jaksani

Since Specialization

Citations

This map shows the geographic impact of Sridevi Jaksani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sridevi Jaksani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sridevi Jaksani more than expected).

Fields of papers citing papers by Sridevi Jaksani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sridevi Jaksani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sridevi Jaksani. The network helps show where Sridevi Jaksani may publish in the future.

Co-authorship network of co-authors of Sridevi Jaksani

This figure shows the co-authorship network connecting the top 25 collaborators of Sridevi Jaksani. A scholar is included among the top collaborators of Sridevi Jaksani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sridevi Jaksani. Sridevi Jaksani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Koorman, Thijs, Lotte Enserink, Daan Visser, et al.. (2022). Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer. Oncogene. 41(21). 2932–2944. 17 indexed citations

2.

Steinhart, Zachary, Zvezdan Pavlovic, Megha Chandrashekhar, et al.. (2016). Genome-wide CRISPR screens reveal a Wnt–FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors. Nature Medicine. 23(1). 60–68. 225 indexed citations

3.

Liu, Jia, Alain van Mil, Sailay Siddiqi, et al.. (2012). MiR‐155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP‐16. Journal of Cellular and Molecular Medicine. 16(10). 2379–2386. 34 indexed citations

4.

Mil, Alain van, Sebastian Grundmann, Marie‐José Goumans, et al.. (2012). MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovascular Research. 93(4). 655–665. 114 indexed citations

5.

Noort, Willy A., Marish I.F.J. Oerlemans, Henk Rozemuller, et al.. (2011). Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. Journal of Cellular and Molecular Medicine. 16(8). 1827–1839. 80 indexed citations

6.

Wilschut, Karlijn J., Sridevi Jaksani, Juliette van den Dolder, Henk P. Haagsman, & Bernard A.J. Roelen. (2008). Isolation and characterization of porcine adult muscle‐derived progenitor cells. Journal of Cellular Biochemistry. 105(5). 1228–1239. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact